A transperineal MRI-ultrasound fusion prostate biopsy is a diagnostic procedure that combines pre-procedure MRI scan images with real-time ultrasound imaging to obtain tissue samples from the prostate gland. The “transperineal” approach means the biopsy needles are inserted through the perineum (the skin between the scrotum and anus) rather than through the rectum.
This procedure uses specialised software to overlay or “fuse” the detailed MRI images onto live ultrasound images during the biopsy. This fusion technology enables urologists to precisely target suspicious areas identified on the MRI scan, improving the accuracy of cancer detection compared to traditional ‘blind’ systematic biopsies.
Studies have shown that MRI-ultrasound fusion biopsies detect clinically significant prostate cancers more effectively than conventional approaches, while reducing the detection of insignificant cancers that may not require immediate treatment.